Middle East: Market for Medicaments Containing Corticosteroid Hormones 2024

Market Size for Medicaments Containing Corticosteroid Hormones in the Middle East

The Middle Eastern medicaments containing corticosteroid hormones market fell sharply to $X in 2022, waning by X% against the previous year. In general, consumption, however, recorded moderate growth. Over the period under review, the market attained the peak level at $X in 2018; however, from 2019 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Corticosteroid Hormones in the Middle East

In value terms, medicaments containing corticosteroid hormones production shrank to $X in 2022 estimated in export price. Overall, production saw a abrupt slump. The most prominent rate of growth was recorded in 2018 with an increase of X%. As a result, production reached the peak level of $X. From 2019 to 2022, production growth remained at a somewhat lower figure.

Exports of Medicaments Containing Corticosteroid Hormones

Exports in the Middle East

In 2022, overseas shipments of medicaments containing corticosteroid hormones increased by X% to X tons, rising for the second year in a row after two years of decline. Total exports indicated a tangible expansion from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, exports increased by X% against 2020 indices. The most prominent rate of growth was recorded in 2017 when exports increased by X% against the previous year. Over the period under review, the exports attained the peak figure at X tons in 2018; however, from 2019 to 2022, the exports stood at a somewhat lower figure.

In value terms, medicaments containing corticosteroid hormones exports expanded notably to $X in 2022. In general, exports, however, showed a abrupt shrinkage. The most prominent rate of growth was recorded in 2014 when exports increased by X% against the previous year. As a result, the exports reached the peak of $X. From 2015 to 2022, the growth of the exports remained at a lower figure.

Exports by Country

Turkey represented the key exporting country with an export of around X tons, which finished at X% of total exports. It was distantly followed by the United Arab Emirates (X tons), generating a X% share of total exports. The following exporters - Saudi Arabia (X tons) and Lebanon (X tons) - each recorded a X% share of total exports.

From 2012 to 2022, the biggest increases were recorded for Turkey (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the United Arab Emirates ($X) remains the largest medicaments containing corticosteroid hormones supplier in the Middle East, comprising X% of total exports. The second position in the ranking was held by Turkey ($X), with a X% share of total exports. It was followed by Saudi Arabia, with a X% share.

In the United Arab Emirates, medicaments containing corticosteroid hormones exports increased at an average annual rate of X% over the period from 2012-2022. The remaining exporting countries recorded the following average annual rates of exports growth: Turkey (X% per year) and Saudi Arabia (X% per year).

Export Prices by Country

The export price in the Middle East stood at $X per ton in 2022, increasing by X% against the previous year. In general, the export price, however, showed a abrupt decline. The pace of growth appeared the most rapid in 2014 when the export price increased by X%. Over the period under review, the export prices attained the maximum at $X per ton in 2012; however, from 2013 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was the United Arab Emirates ($X per ton), while Lebanon ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United Arab Emirates (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Containing Corticosteroid Hormones

Imports in the Middle East

In 2022, overseas purchases of medicaments containing corticosteroid hormones were finally on the rise to reach X tons for the first time since 2018, thus ending a three-year declining trend. Total imports indicated perceptible growth from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2018 with an increase of X%. As a result, imports reached the peak of X tons. From 2019 to 2022, the growth of imports failed to regain momentum.

In value terms, medicaments containing corticosteroid hormones imports shrank to $X in 2022. Total imports indicated temperate growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by X% against 2019 indices. The growth pace was the most rapid in 2018 when imports increased by X%. The level of import peaked at $X in 2019; however, from 2020 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, the United Arab Emirates (X tons) represented the largest importer of medicaments containing corticosteroid hormones, mixing up X% of total imports. It was distantly followed by Saudi Arabia (X tons), Turkey (X tons), Iraq (X tons), Iran (X tons) and Kuwait (X tons), together achieving a X% share of total imports. Oman (X tons) followed a long way behind the leaders.

The United Arab Emirates was also the fastest-growing in terms of the medicaments containing corticosteroid hormones imports, with a CAGR of X% from 2012 to 2022. At the same time, Oman (X%), Iraq (X%), Kuwait (X%), Iran (X%) and Turkey (X%) displayed positive paces of growth. By contrast, Saudi Arabia (X%) illustrated a downward trend over the same period. While the share of the United Arab Emirates (X p.p.) and Iraq (X p.p.) increased significantly in terms of the total imports from 2012-2022, the share of Turkey (X p.p.) and Saudi Arabia (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the United Arab Emirates ($X), Turkey ($X) and Saudi Arabia ($X) were the countries with the highest levels of imports in 2022, together accounting for X% of total imports. Kuwait, Iraq, Iran and Oman lagged somewhat behind, together comprising a further X%.

Oman, with a CAGR of X%, saw the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in the Middle East stood at $X per ton in 2022, falling by X% against the previous year. Overall, the import price recorded a mild contraction. The most prominent rate of growth was recorded in 2019 an increase of X% against the previous year. As a result, import price reached the peak level of $X per ton. From 2020 to 2022, the import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Kuwait ($X per ton), while the United Arab Emirates ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Oman (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :